News
How cholera bacteria from Latin America's WASA lineage used viral defense tools to resist phage attacks, fueling a deadly ...
Empowering health in vulnerable groups through timely statin use, alcohol recovery support, and cash aid for mothers to build ...
Multiple Sclerosis affects millions worldwide with diverse symptoms; early diagnosis, multidisciplinary care, and awareness ...
Learn to understand the five distinct baby cries that indicate hunger, sleep, discomfort, gas, and the need to burp. Respond ...
Children's breakfast cereals are getting saltier and sweeter, with new products showing higher fat and sugar but lower ...
As awareness around sustainability and menstrual health grows, more women are making the switch to reusable period products. A recent Intimina survey reveals that 88.22% of respondents use reusable ...
Global pharma major Lupin Limited (Lupin) will present data from its Phase 1a clinical trial evaluating LNP7457, a PRMT5 inhibitor, at the American Society of Clinical Oncology (ASCO) annual meeting ...
A groundbreaking study published in the Journal of Molecular Diagnostics reports the successful clinical validation of SeekInCare ® , a novel, non-invasive multi-omics blood test ...
Gilgamesh Pharmaceuticals, a clinical-stage neuroscience company developing innovative, best-in-class new chemical entities (NCEs) that tran ...
Acne Medicine Market is Segmented by Type (OTC, Prescription Medicine), by Application (Topical, Oral). Major Factors Driving the Growth of Acne Medicine Market: The acne medicine market is ...
Women in Media and Marketing Awards honorees are: "As Breastcancer.org celebrates 25 years of empowering people with trusted information and support, we are proud to hono ...
Abbisko Therapeutics (HKEX Code: 02256) announced that its self-developed, highly selective small molecule FGFR4 inhibitor, irpagratinib (ABSK011), has received approval of Breakthrough ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results